Image source: The Motley Fool. Wednesday, Feb. 4, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Jerome Grant Chief Financial Officer — Bruce Schuman Senior Vice President, Investor Relations — Matt Kempton TAKEAWAYS Revenue -- $220.8 million, up 9.6%, driven by $78 million at Concord (up 11.5%) and $142.8 million at the UTI division (up 8.6%). -- $220.8 million, up 9.6%, driven ...
Image source: The Motley Fool. Wednesday, Feb. 4, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Jerome Grant Chief Financial Officer — Bruce Schuman Senior Vice President, Investor Relations — Matt Kempton TAKEAWAYS Revenue -- $220.8 million, up 9.6%, driven by $78 million at Concord (up 11.5%) and $142.8 million at the UTI division (up 8.6%). -- $220.8 million, up 9.6%, driven by $78 million at Concord (up 11.5%) and $142.8 million at the UTI division (up 8.6%). Baseline Adjusted EBITDA -- $34.7 million, including $7.6 million in growth investments; reported adjusted EBITDA was $27.1 million. -- $34.7 million, including $7.6 million in growth investments; reported adjusted EBITDA was $27.1 million. Net Income -- $12.8 million, equating to $0.23 per diluted share, with 55 million shares outstanding. -- $12.8 million, equating to $0.23 per diluted share, with 55 million shares outstanding. Average Full-Time Active Students -- Grew 7.2% to 26,858, with Concord division up 9.5% and UTI division up 5.7%. -- Grew 7.2% to 26,858, with Concord division up 9.5% and UTI division up 5.7%. New Student Starts -- Rose 2.6% to 5,449; management highlighted this as "in line with the outlook we shared last quarter." -- Rose 2.6% to 5,449; management highlighted this as "in line with the outlook we shared last quarter." Liquidity -- $233.2 million, consisting of $69.2 million in short-term investments and $70.4 million of undrawn revolving credit facility. -- $233.2 million, consisting of $69.2 million in short-term investments and $70.4 million of undrawn revolving credit facility. Capital Expenditures -- $24 million year-to-date, or 24% of planned $100 million full-year spend; $19 million of Q1 CapEx was growth-focused. -- $24 million year-to-date, or 24% of planned $100 million full-year spend; $19 million of Q1 CapEx was growth-focused. Guidance Reaffirmed -- Full-year revenue projected at $905 million to $915 million (approximately 9% growth at midpoint), bas...
Maskot/DigitalVision via Getty Images The way market forces are shaping up, 2026 could be a very volatile year, and one of the biggest losers is a group of stocks that many had thought to be immune to pessimism: software stocks. The selloff in software companies has reached an extreme, with many investors fearing that AI will encroach on core enterprise software apps and deliver huge blows to paid...
Maskot/DigitalVision via Getty Images The way market forces are shaping up, 2026 could be a very volatile year, and one of the biggest losers is a group of stocks that many had thought to be immune to pessimism: software stocks. The selloff in software companies has reached an extreme, with many investors fearing that AI will encroach on core enterprise software apps and deliver huge blows to paid seat counts. Intapp, Inc. ( INTA ), the vertical software company that serves banks, investment firms, and legal offices, has been one of the core decliners. The stock has wiped out two thirds of its market value over the last year, despite maintaining double-digit revenue growth and healthy profits. The company just reported a strong fiscal Q2 beat and raise, which yielded a ~20% drop post earnings. In my view, this selloff has gone too far. Data by YCharts I last wrote a buy article on Intapp in January , when the stock was trading near $38 per share. At a volatile market juncture, I think it’s more important than ever that we separate the desire to try to time our investments perfectly from making sound investments overall. Intapp has completely lost momentum: but a sober look at the stock reveals a vibrant business that is adding clients, expanding with existing ones, and boosting its bottom line. I see no red flags here, and I am reiterating my buy rating on the stock. As a reminder for investors who are newer to this stock, here is what I consider to be the long-term bull case for Intapp: Intapp serves a broad $46 billion TAM. The company’s current revenue run rate of below $0.6 billion is barely over 1% penetrated into the company’s overall total addressable market, indicating plenty of greenfield room for expansion. Recurring revenue base- Intapp generates nearly pure recurring revenue, and ARR is growing at north of a 20% pace. Cloud ARR is growing at an even faster +30% y/y pace. The large proportion of recurring revenue makes it unlikely that Intapp will see a l...
On Feb. 2, 2026, Sterling Investment Management, LLC disclosed a new position in Vanguard Institutional Index Funds - Vanguard 0-3 Month Treasury Bill ETF (NASDAQ:VBIL) , acquiring 39,433 shares in an estimated $2.97 million trade based on quarterly average pricing. According to an SEC filing dated Feb. 2, 2026, Sterling Investment Management, LLC established a new position in Vanguard Institution...
On Feb. 2, 2026, Sterling Investment Management, LLC disclosed a new position in Vanguard Institutional Index Funds - Vanguard 0-3 Month Treasury Bill ETF (NASDAQ:VBIL) , acquiring 39,433 shares in an estimated $2.97 million trade based on quarterly average pricing. According to an SEC filing dated Feb. 2, 2026, Sterling Investment Management, LLC established a new position in Vanguard Institutional Index Funds - Vanguard 0-3 Month Treasury Bill ETF, acquiring 39,433 shares during the fourth quarter of 2025. The transaction is estimated at $2.97 million based on the average price over the quarter. The quarter-end value of the position also stands at $2.97 million, reflecting both the purchase and subsequent price shifts. Vanguard 0-3 Month Treasury Bill ETF provides investors with a low-risk vehicle for short-term capital allocation by tracking an index of high-quality U.S. Treasury bills. The fund's strategy emphasizes liquidity and principal stability through a diversified portfolio of short-maturity government securities. Its competitive advantage lies in its disciplined sampling approach and its focus on minimizing interest-rate risk for conservative investors. Continue reading
Analog chipmaker SiTime Corp. has agreed to acquire Renesas Electronics Corp. ’s timing unit in a cash-and-stock transaction valued at about $2.9 billion. SiTime said in a joint statement with Renesas that it’s buying the business for $1.5 billion in cash and 4.13 million of its shares, which closed Wednesday at $347.96 apiece. SiTime is funding the cash portion with cash on hand and $900 million ...
Analog chipmaker SiTime Corp. has agreed to acquire Renesas Electronics Corp. ’s timing unit in a cash-and-stock transaction valued at about $2.9 billion. SiTime said in a joint statement with Renesas that it’s buying the business for $1.5 billion in cash and 4.13 million of its shares, which closed Wednesday at $347.96 apiece. SiTime is funding the cash portion with cash on hand and $900 million in a fully committed debt financing from Wells Fargo & Co. , according to the statement. The companies said that Renesas Chief Executive Officer Hidetoshi Shibata will join SiTime’s board after the transaction closes, which is expected by the end of the year. The statement confirmed an earlier report by Bloomberg News that the companies were nearing a deal. The Renesas division makes the clocks that synchronize signals in wireless infrastructure. Shares of Renesas have gained 27% in the past year in Tokyo, for a market capitalization of about ¥4.8 trillion ($31 billion). Shares of SiTime have surged 62% during the same period, giving it a market value of about $9.1 billion. Santa Clara, California-based SiTime specializes in silicon oscillators and resonators that keep complex circuits in sync inside artificial intelligence data centers. Nintendo Co. supplier MegaChips Corp. , based in Osaka, holds a stake in SiTime. The deal is SiTime’s largest acquisition to date, according to data compiled by Bloomberg. Selling the unit gives Renesas more funds to chase acquisitions in high-growth areas and move toward a platform-based business. The maker of automotive chips in 2024 bought US-based Altium Ltd., a provider of electronic design software, as part of a shift away from one-off product sales.
Earnings Call Insights: Vishay Intertechnology (VSH) Q4 2025 Management View Joel Smejkal, President, CEO & Director, reported fourth quarter revenue of $801 million, which was “slightly above the midpoint of our guidance of $790 million and 1.3% higher than the third quarter.” He attributed sequential growth to “a growing broad-based business in Industrial Power and AI-related power applications,...
Earnings Call Insights: Vishay Intertechnology (VSH) Q4 2025 Management View Joel Smejkal, President, CEO & Director, reported fourth quarter revenue of $801 million, which was “slightly above the midpoint of our guidance of $790 million and 1.3% higher than the third quarter.” He attributed sequential growth to “a growing broad-based business in Industrial Power and AI-related power applications,” with Asia leading revenue growth. Smejkal highlighted that “orders for the fourth quarter are at a 3-year high across all main product technologies, except capacitors, which reached their 3-year high already in Q2 of '25.” Smejkal stated that the company’s “order growth was broad-based in each region, each channel, each of our technologies and each of our growth end markets, Automotive, Industrial Power, Aerospace-Defense, AI Computing and Healthcare,” which represent about 95% of Vishay’s core business. He also noted, “fourth quarter backlog grew nearly 14% with both semis and passives contributing to the increase.” Smejkal detailed ongoing investments, saying, “Our work under Vishay 3.0 is becoming visible in our revenue generation… We are making it possible through our heavy investment over the past 3 years to expand capacity for our high-growth, high-profit products.” David McConnell, Executive VP & CFO, reported, “Fourth quarter revenue was $801 million, exceeding the midpoint of our guidance and increasing 1% sequentially… Gross profit was $157 million, resulting in a gross margin of 19.6%, modestly above both the midpoint of our guidance and the third quarter.” He added, “EBITDA for the quarter was $70 million for an EBITDA margin of 8.8%, down from 9.6% in the third quarter.” Outlook For the first quarter of 2026, McConnell guided, “revenues are expected to be between $800 million and $830 million.” He added, “We expect Asia revenue to be lower than Q4 due to the impact of the Lunar New Year with the Americas and Europe regions making up the difference.” Vishay ex...
Key Takeaways AMD CEO Lisa Su told CNBC Wednesday that demand for the company's chips is “on fire” and that she sees this as an "inflection year" for the company as it rolls out its next-generation products. Shares of AMD slumped Wednesday despite results that topped Wall Street's estimates. Investors dropped shares of Advanced Micro Devices after its latest earnings. Its CEO says they should be e...
Key Takeaways AMD CEO Lisa Su told CNBC Wednesday that demand for the company's chips is “on fire” and that she sees this as an "inflection year" for the company as it rolls out its next-generation products. Shares of AMD slumped Wednesday despite results that topped Wall Street's estimates. Investors dropped shares of Advanced Micro Devices after its latest earnings. Its CEO says they should be excited about what's ahead this year. Shares of AMD (AMD), regarded by some as a top alternative to AI chip leader Nvidia (NVDA), plunged over 17% Wednesday, leaving them in the red year-to-date despite quarterly earnings that topped Wall Street estimates. Analysts said lofty expectations, along with concerns that a surprise boost from China sales may have helped smooth over softer growth elsewhere, and uncertainty about the competitiveness of its next generation of products, weighed on sentiment. Lisa Su, however, is upbeat. Why This Is Significant AMD, long seen as a second fiddle to chip industry leader Nvidia, could face a big test this year with its latest AI products set to launch in the second half. She told CNBC in a televised interview Wednesday that demand for its chips is “on fire” with the results showing “strength across the entire business.” The CEO also said she sees 2026 as a “big inflection year” for the company, as it prepares to roll out its next generation of AI chips in the second half. Revenue from AMD's MI450, designed to compete with Nvidia’s Rubin chips, is expected to start contributing to AMD’s revenue in the third quarter, Su told investors during a conference call Tuesday, according to a transcript provided by AlphaSense. Su, who told CNBC that AI is “accelerating at a pace I would not have imagined,” projected that AMD's data center segment—responsible for the bulk of its revenue—could rise more than 60% annually over the next three to five years as the industry grows. AMD's shares finished the day around $200 apiece, dropping further below Wall...
Key Takeaways AMD CEO Lisa Su told CNBC Wednesday that demand for the company's chips is “on fire” and that she sees this as an "inflection year" for the company as it rolls out its next-generation products. Shares of AMD slumped Wednesday despite results that topped Wall Street's estimates. Investors dropped shares of Advanced Micro Devices after its latest earnings. Its CEO says they should be e...
Key Takeaways AMD CEO Lisa Su told CNBC Wednesday that demand for the company's chips is “on fire” and that she sees this as an "inflection year" for the company as it rolls out its next-generation products. Shares of AMD slumped Wednesday despite results that topped Wall Street's estimates. Investors dropped shares of Advanced Micro Devices after its latest earnings. Its CEO says they should be excited about what's ahead this year. Shares of AMD (AMD), regarded by some as a top alternative to AI chip leader Nvidia (NVDA), plunged over 17% Wednesday, leaving them in the red year-to-date despite quarterly earnings that topped Wall Street estimates. Analysts said lofty expectations, along with concerns that a surprise boost from China sales may have helped smooth over softer growth elsewhere, and uncertainty about the competitiveness of its next generation of products, weighed on sentiment. Lisa Su, however, is upbeat. Why This Is Significant AMD, long seen as a second fiddle to chip industry leader Nvidia, could face a big test this year with its latest AI products set to launch in the second half. She told CNBC in a televised interview Wednesday that demand for its chips is “on fire” with the results showing “strength across the entire business.” The CEO also said she sees 2026 as a “big inflection year” for the company, as it prepares to roll out its next generation of AI chips in the second half. Revenue from AMD's MI450, designed to compete with Nvidia’s Rubin chips, is expected to start contributing to AMD’s revenue in the third quarter, Su told investors during a conference call Tuesday, according to a transcript provided by AlphaSense. Su, who told CNBC that AI is “accelerating at a pace I would not have imagined,” projected that AMD's data center segment—responsible for the bulk of its revenue—could rise more than 60% annually over the next three to five years as the industry grows. AMD's shares finished the day around $200 apiece, dropping further below Wall...
Investing.com -- Nvidia is negotiating with the U.S. government regarding license terms to ship its H200 AI chips to companies in China, according to a Reuters report late Wednesday. The Trump administration reportedly indicated about two weeks ago it would approve a license allowing China's ByteDance to purchase Nvidia's H200 chips. However, Nvidia has not yet accepted certain U.S. government con...
Investing.com -- Nvidia is negotiating with the U.S. government regarding license terms to ship its H200 AI chips to companies in China, according to a Reuters report late Wednesday. The Trump administration reportedly indicated about two weeks ago it would approve a license allowing China's ByteDance to purchase Nvidia's H200 chips. However, Nvidia has not yet accepted certain U.S. government conditions, including Know-Your-Customer (KYC) requirements designed to prevent China's military from accessing the chips. In a statement quoted by Reuters, Nvidia explained its position as an intermediary between the U.S. government and potential customers who would need to comply with U.S. restrictions. "We aren't able to accept or reject license conditions on our own," a company spokesperson said. "Although KYC is important, KYC is not the issue. For American industry to make any sales, the conditions need to be commercially practical, else the market will continue to move to foreign alternatives." The U.S. is expected to eventually allow Nvidia to sell H200s and similar chips from AMD to China, as President Donald Trump has personally approved these sales, once national security concerns are addressed. Related articles Nvidia and Trump admin yet to agree on terms of H200 sales to TikTok Goldman expects lower but still attractive stock market returns in 2026 Wolfe Research outlines eight risks that could spark stock declines in 2026
Key Points UnitedHealth's earnings plummeted 41% last year. The company expects a modest improvement in earnings this year, but its cash flow is projected to decline. The stock has been crashing in recent years, resulting in a higher-than-typical yield for investors. 10 stocks we like better than UnitedHealth Group › If you're investing in a dividend stock, it's important to track its performance ...
Key Points UnitedHealth's earnings plummeted 41% last year. The company expects a modest improvement in earnings this year, but its cash flow is projected to decline. The stock has been crashing in recent years, resulting in a higher-than-typical yield for investors. 10 stocks we like better than UnitedHealth Group › If you're investing in a dividend stock, it's important to track its performance to see if there are any warning signs that might affect its ability to pay its current rate of dividends in the future. It's those early signs that can save you from a huge disappointment later on. One stock investors have been worried about these days is UnitedHealth Group (NYSE: UNH). While it's a top health insurer in the country, rising medical costs have been weighing on its financials, and the stock price has been declining. However, with a dividend yield of 3%, it may be an enticing option for income-seeking investors, especially when you consider that the S&P 500's average yield is just 1.1%. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » But with UnitedHealth's recent earnings numbers not looking all that strong of late, the big question is whether that dividend is really safe. Let's take a closer look. UnitedHealth's earnings from operations declined by 41% in 2025 Last week, UnitedHealth posted its year-end earnings numbers, and they weren't great. While revenue of $447.6 billion rose by 12% year over year, its earnings from operations were down by 41%, totaling just under $19 billion. There was a lot of noise on its financials, however, as the company incurred expenses related to restructuring efforts, workforce reductions, and a previous cyberattack. The bigger concern is that the healthcare company has been battling rising medical costs, and that has made investors think twice about owning the stock. Looking ahead, the company's guidance calls for earnings from operations t...
Image source: The Motley Fool. Wednesday, Feb. 4, 2026 at 4:30 p.m. ET Call participants Chief Executive Officer — Tarang Amin Chief Financial Officer — Mandy Fields Takeaways Net sales growth -- 38% increase, with Rhode acquisition contributing $128 million, representing approximately 36 percentage points of growth. -- 38% increase, with Rhode acquisition contributing $128 million, representing a...
Image source: The Motley Fool. Wednesday, Feb. 4, 2026 at 4:30 p.m. ET Call participants Chief Executive Officer — Tarang Amin Chief Financial Officer — Mandy Fields Takeaways Net sales growth -- 38% increase, with Rhode acquisition contributing $128 million, representing approximately 36 percentage points of growth. -- 38% increase, with Rhode acquisition contributing $128 million, representing approximately 36 percentage points of growth. Adjusted EBITDA -- $123 million for the quarter, up 79% from the prior year. -- $123 million for the quarter, up 79% from the prior year. Adjusted net income -- $74 million, or $1.24 per diluted share, compared to $43 million, or $0.74 per diluted share, last year. -- $74 million, or $1.24 per diluted share, compared to $43 million, or $0.74 per diluted share, last year. Gross margin -- 71%, down approximately 30 basis points year over year, up 200 basis points sequentially from Q2, reflecting tariff impacts partially offset by pricing and mix. -- 71%, down approximately 30 basis points year over year, up 200 basis points sequentially from Q2, reflecting tariff impacts partially offset by pricing and mix. SG&A as % of sales -- Adjusted SG&A was 51%, reduced from 54% the previous year, aided by leveraged marketing and a shift of some SG&A expenses into Q4. -- Adjusted SG&A was 51%, reduced from 54% the previous year, aided by leveraged marketing and a shift of some SG&A expenses into Q4. Marketing spend -- 21% of net sales for the quarter, down from 27% the previous year; annual guidance remains at 24%-26% of net sales. -- 21% of net sales for the quarter, down from 27% the previous year; annual guidance remains at 24%-26% of net sales. U.S. vs. international sales growth -- Net sales in the U.S. grew 36%; international net sales rose 44%. -- Net sales in the U.S. grew 36%; international net sales rose 44%. Organic net sales -- Up approximately 2% year over year, with lower-than-expected results in the UK and Germany cited as driv...
(RTTNews) - WEX Inc. (WEX) reported earnings for its fourth quarter that Increases, from the same period last year The company's earnings came in at $84.3 million, or $2.41 per share. This compares with $63.9 million, or $1.60 per share, last year. Excluding items, WEX Inc. reported adjusted earnings of $143.7 million or $4.11 per share for the period. The company's revenue for the period rose 5.7...
(RTTNews) - WEX Inc. (WEX) reported earnings for its fourth quarter that Increases, from the same period last year The company's earnings came in at $84.3 million, or $2.41 per share. This compares with $63.9 million, or $1.60 per share, last year. Excluding items, WEX Inc. reported adjusted earnings of $143.7 million or $4.11 per share for the period. The company's revenue for the period rose 5.7% to $672.9 million from $636.5 million last year. WEX Inc. earnings at a glance (GAAP) : -Earnings: $84.3 Mln. vs. $63.9 Mln. last year. -EPS: $2.41 vs. $1.60 last year. -Revenue: $672.9 Mln vs. $636.5 Mln last year. -Guidance: Next quarter EPS guidance: $ 3.80 To $ 4.00 Next quarter revenue guidance: $ 650 M To $ 670 M The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Image source: The Motley Fool. Wednesday, February 4, 2026 at 5 p.m. ET CALL PARTICIPANTS President and Chief Executive Officer — Ronald E. Konezny Chief Financial Officer — Jamie Loch Need a quote from a Motley Fool analyst? Email [email protected] RISKS Jamie Loch stated, "are battling our way through, you know, the highly publicized memory challenges that AI expansion has created," which may af...
Image source: The Motley Fool. Wednesday, February 4, 2026 at 5 p.m. ET CALL PARTICIPANTS President and Chief Executive Officer — Ronald E. Konezny Chief Financial Officer — Jamie Loch Need a quote from a Motley Fool analyst? Email [email protected] RISKS Jamie Loch stated, "are battling our way through, you know, the highly publicized memory challenges that AI expansion has created," which may affect component costs and supply. Ronald E. Konezny identified volatility in market prices for DDR4 and DDR5 memory, highlighting that in some cases, "you may issue a PO and that PO actually is accepted with a condition that price may be subject to change." TAKEAWAYS Revenue -- $122 million, up 18% year over year, setting an all-time company record. -- $122 million, up 18% year over year, setting an all-time company record. Annualized Recurring Revenue (ARR) -- $157 million, up 31% year over year, driven by both IoT Solutions (up 32%) and IoT Products & Services (up 26%). -- $157 million, up 31% year over year, driven by both IoT Solutions (up 32%) and IoT Products & Services (up 26%). Adjusted EBITDA -- $32 million, up 23% year over year, achieving a record 25.8% margin. -- $32 million, up 23% year over year, achieving a record 25.8% margin. Quarterly Cash Generation -- $36 million, cited as a key highlight by management. -- $36 million, cited as a key highlight by management. Particle Acquisition -- Contributes $20 million in ARR and is expected to add $13 million to $14 million in revenue for fiscal 2026; anticipated adjusted EBITDA contribution ranges from $1 million to $2 million in fiscal 2026 and $5 million in fiscal 2027. -- Contributes $20 million in ARR and is expected to add $13 million to $14 million in revenue for fiscal 2026; anticipated adjusted EBITDA contribution ranges from $1 million to $2 million in fiscal 2026 and $5 million in fiscal 2027. Guidance for Fiscal 2026 -- Anticipates ARR growth of 23%, revenue growth of 14%-18%, and adjusted EBITDA growth of...
Key Points Micron is a leader in the hot DRAM market. Sandisk is a pure-play way to invest in the surging NAND market. 10 stocks we like better than Micron Technology › The hottest segment of the market right now is memory stocks. This once cyclical industry is now entering a supercycle and is one of the most intriguing ways to play artificial intelligence (AI). The memory market is on fire The me...
Key Points Micron is a leader in the hot DRAM market. Sandisk is a pure-play way to invest in the surging NAND market. 10 stocks we like better than Micron Technology › The hottest segment of the market right now is memory stocks. This once cyclical industry is now entering a supercycle and is one of the most intriguing ways to play artificial intelligence (AI). The memory market is on fire The memory market is split into two parts: DRAM (dynamic random access memory) and NAND (flash memory). Given its speed, DRAM is used for short-term memory, while NAND tends to be used for long-term storage since it is slower. Both markets face significant supply constraints, which are leading to DRAM and NAND prices skyrocketing. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks » Image source: Getty Images For AI chips to perform optimally, they need to be packaged with a special form of DRAM called high-bandwidth memory (HBM). When integrated with HBM, graphics processing units (GPUs) and other AI chips can perform calculations faster because they can quickly store, retrieve, and transfer data using the HBM component. Given the AI infrastructure buildout, HBM, unsurprisingly, is in high demand. Adding to the market dynamics is that HBM uses three to four times the wafer capacity of conventional DRAM. This is causing a supply shortage across the entire DRAM industry, which is leading to soaring prices not just for HBM, but for the entire DRAM market. Flash memory, meanwhile, is also in tight supply. The NAND market became very oversupplied a few years ago, and prices crashed to the point where gross margins turned negative. Given this, memory companies began redirecting resources to other areas, lowering their production capabilities. However, with the rise of AI, demand for massive, high-performance solid-state drives (SSDs) using flash memory to store training...
Generate Biomedicines Inc. filed for an initial public offering, joining a growing list of biotechnology firms to leap to public markets as investors embrace the sector. The Somerville, Massachusetts-based drug developer’s lead product candidate is being studied in severe asthma and chronic obstructive pulmonary disease (COPD), according to Generate’s filing Wednesday with the US Securities and Ex...
Generate Biomedicines Inc. filed for an initial public offering, joining a growing list of biotechnology firms to leap to public markets as investors embrace the sector. The Somerville, Massachusetts-based drug developer’s lead product candidate is being studied in severe asthma and chronic obstructive pulmonary disease (COPD), according to Generate’s filing Wednesday with the US Securities and Exchange Commission. The company’s late-stage trials for severe asthma are expected to be fully enrolled later next year or in the first half of 2028 with early-stage data from the COPD study expected in the first half of this year, the filing shows. Generate raised $273 million in a Series C financing in 2023 which attracted investors including Amgen Inc. , Nvidia Corp. ’s venture capital arm, MAPS Capital (Mirae Asset Group) and Pictet Alternative Advisors. Board chair Noubar Afeyan owns more than half of the shares, according to the filing. Afeyan leads Flagship Pioneering, an investment firm that creates and backs biotech companies, and co-founded Moderna Inc. For the latest news on equity capital markets activity in the US, Canada and Latin America, follow the channel or visit NI BFWECMUS . To subscribe to ECM Watch , Bloomberg’s daily roundup of news from around the region, click here . Generate Biomedicines had a net loss of $223 million last year, versus a net loss of $181 million in 2024, according to its filing. The offering is being led by Goldman Sachs Group Inc. and Morgan Stanley . The company plans for its shares to trade on the Nasdaq Stock Market under the symbol GENB.